Cargando...
CAR T-cell therapy: is it prime time in myeloma?
Chimeric antigen receptor (CAR) T cells have shown promising activity in hematological malignancies and are being studied for the treatment of multiple myeloma, as well. B-cell maturation antigen, which is widely and almost exclusively expressed on plasma cells and B cells, is a promising target. Ot...
Guardado en:
| Publicado en: | Blood Adv |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855102/ https://ncbi.nlm.nih.gov/pubmed/31714964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000370 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|